A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
Clinical trial NCT07154745 · RECRUITING
Trial details
- NCT number
- NCT07154745
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-11
- Primary completion
- 2030-01-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.